Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-01

Clinical Trial Update: Study 3: Minocycline Decreases Microglia Activation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating minocycline's effect on microglia activation in hypertension completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: University of Florida | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2025-07-01